Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Ten replicated measurements of each condition were performed. (B) Induction of antigen-specific autologous proliferation against TT mediated by immature DC (iDC), mature DC (mDC), TT-loaded mDC (mDC-TT), vitamin D3-induced tolerogenic DC (vitD3-tolDC) and TT-loaded vitD3-tolDC (vitD3-tolDC-TT), as well as a negative control (C−), without any stimuli (n = 16) and (C) comparison of autologous antigen-specific proliferation against TT mediated by mDC-TT and vitD3-tolDC-TT on each donor.

Source: VitD3-tolDC-TT Induce an Antigen-Specific Response Over Autologous PBMC. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness

Study design awaiting verification · Frontiers in Immunology · 2021

Original publication title

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness

Juan Navarro-Barriuso; María José Mansilla; Bibiana Quirant-Sánchez; Aina Teniente-Serra; Cristina Ramo-Tello; Eva M. Martínez-Cáceres

Copyright © 2021 Navarro-Barriuso, Mansilla, Quirant-Sánchez, Teniente-Serra, Ramo-Tello and Martínez-Cáceres

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The use of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases. Among the different strategies available, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most robust approaches due to their immune regulatory properties, which are currently being tested in clinical trials. However, the mechanisms that vitD3-tolDC trigger for the induction of tolerance remain elusive. For this reason, we performed a full phenotypical, functional, and transcriptomic characterization of T cells upon their interaction with autologous, antigen-specific vitD3-tolDC.

We observed a strong antigen-specific reduction of T cell proliferation, combined with a decrease in the relative prevalence of TH1 subpopulations and IFN-γ production. The analysis of the transcriptomic profile of T CD4+ cells evidenced a significant down-modulation of genes involved in cell cycle and cell response to mainly pro-inflammatory immune-related stimuli, highlighting the role of JUNB gene as a potential biomarker of these processes. Consequently, our results show the induction of a strong antigen-specific hyporesponsiveness combined with a reduction on the TH1 immune profile of T cells upon their interaction with vitD3-tolDC, which manifests the regulatory properties of these cells and, therefore, their therapeutic potential in the clinic.

Authors’ abstract

The use of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases. Among the different strategies available, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most robust approaches due to their immune regulatory properties, which are currently being tested in clinical trials. However, the mechanisms that vitD3-tolDC trigger for the induction of tolerance remain elusive. For this reason, we performed a full phenotypical, functional, and transcriptomic characterization of T cells upon their interaction with autologous, antigen-specific vitD3-tolDC.

We observed a strong antigen-specific reduction of T cell proliferation, combined with a decrease in the relative prevalence of TH1 subpopulations and IFN-γ production. The analysis of the transcriptomic profile of T CD4+ cells evidenced a significant down-modulation of genes involved in cell cycle and cell response to mainly pro-inflammatory immune-related stimuli, highlighting the role of JUNB gene as a potential biomarker of these processes. Consequently, our results show the induction of a strong antigen-specific hyporesponsiveness combined with a reduction on the TH1 immune profile of T cells upon their interaction with vitD3-tolDC, which manifests the regulatory properties of these cells and, therefore, their therapeutic potential in the clinic.

Publication and source details

Original title: Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness

Juan Navarro-Barriuso; María José Mansilla; Bibiana Quirant-Sánchez; Aina Teniente-Serra; Cristina Ramo-Tello; Eva M. Martínez-Cáceres

Frontiers in Immunology · 2021

Edited by: Fang Zhou, CAS Lamvac Biotech Co., Ltd., China

Reviewed by: Ali Akbar Pourfathollah, Tarbiat Modares University, Iran; Paulina A. García-González, University of Chile, Chile; Willem Van Eden, Utrecht University, Netherlands; Carolina Llanos, Pontificia Universidad Católica de Chile, Chile; Grant P. Parnell, Westmead Institute for Medical Research, Australia

*Correspondence: Eva M. Martínez-Cáceres, emmartinez.germanstrias@gencat.cat

This article was submitted to Immunological Tolerance and Regulation, a section of the journal Frontiers in Immunology

Copyright © 2021 Navarro-Barriuso, Mansilla, Quirant-Sánchez, Teniente-Serra, Ramo-Tello and Martínez-Cáceres2021Navarro-Barriuso, Mansilla, Quirant-Sánchez, Teniente-Serra, Ramo-Tello and Martínez-Cácereshttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Instituto de Salud Carlos III10.13039/501100004587PI14/01175, PI16/01737, PI17/01521Agentschap voor Innovatie door Wetenschap en Technologie10.13039/501100003132140191Agència de Gestió d'Ajuts Universitaris i de Recerca10.13039/5011000030302017 SGR 103Horizon 2020 Framework Programme10.13039/100010661BM1305, ReSToRe: 779316

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:16:23.222379+00:00

DOI: 10.3389/fimmu.2020.599623 · PMC7856150